• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用胰岛素和葡萄糖治疗高钾血症的估算肾小球滤过率低的患者发生低血糖的发生率。

Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia.

作者信息

Pierce Dwayne A, Russell Greg, Pirkle James L

机构信息

Georgia Regents University Medical Center, Augusta, GA, USA

Wake Forest University School of Medicine, Winston-Salem, NC, USA.

出版信息

Ann Pharmacother. 2015 Dec;49(12):1322-6. doi: 10.1177/1060028015607559. Epub 2015 Sep 28.

DOI:10.1177/1060028015607559
PMID:26416951
Abstract

BACKGROUND

Hyperkalemia is a potentially life-threatening condition that is common in kidney disease patients. Insulin is used to treat hyperkalemia, but may cause hypoglycemia, especially in kidney disease when insulin may be metabolized more slowly.

OBJECTIVE

We compared the rates of hypoglycemia in patients with low estimated glomerular filtration rate (eGFR) using high versus low doses of insulin for hyperkalemia to determine if lower doses of insulin would decrease the incidence of hypoglycemia.

METHODS

This was a retrospective study of hospitalized patients receiving intravenous insulin for hyperkalemia during a 6-month period. Patients with low eGFR were analyzed based on how much insulin they received: high dose (10 units, n = 78) versus low dose (5 units, n = 71). Postdose nadir blood glucose values were examined for up to 8 hours after the dose. The percentage of hypoglycemia (blood glucose ≤70 mg/dl) and a subset of severe hypoglycemia (blood glucose <50 mg/dl) were then reported for each dose group.

RESULTS

A total of 149 doses were identified in patients with low eGFR. The rates of hypoglycemia were 16.7% and 19.7% (P = 0.79), respectively, among high-dose (n = 78) and low-dose (n = 71) groups. Rates of severe hypoglycemia were 8.9% and 7.0%, respectively (P = 0.90). More than 28% of hypoglycemic episodes with high doses occurred after 4 hours (median = 2.5 hours) compared with 14.3% with low doses (median = 2.38 hours).

CONCLUSION

There was no difference in the rate of hypoglycemia or severe hypoglycemia between high or low doses of insulin in patients with low eGFR. We recommend monitoring up to 6 hours after insulin use in hyperkalemia.

摘要

背景

高钾血症是一种可能危及生命的疾病,在肾病患者中很常见。胰岛素用于治疗高钾血症,但可能会导致低血糖,尤其是在肾病患者中,因为胰岛素的代谢可能会更慢。

目的

我们比较了估算肾小球滤过率(eGFR)低的患者使用高剂量与低剂量胰岛素治疗高钾血症时的低血糖发生率,以确定较低剂量的胰岛素是否会降低低血糖的发生率。

方法

这是一项对6个月内接受静脉注射胰岛素治疗高钾血症的住院患者的回顾性研究。根据估算肾小球滤过率低的患者接受胰岛素的剂量对其进行分析:高剂量组(10单位,n = 78)和低剂量组(5单位,n = 71)。在给药后长达8小时内检查给药后的最低血糖值。然后报告每个剂量组的低血糖发生率(血糖≤70mg/dl)和严重低血糖的一个子集(血糖<50mg/dl)。

结果

在估算肾小球滤过率低的患者中总共确定了149次给药。高剂量组(n = 78)和低剂量组(n = 71)的低血糖发生率分别为16.7%和19.7%(P = 0.79)。严重低血糖发生率分别为8.9%和7.0%(P = 0.90)。高剂量组超过28%的低血糖发作发生在4小时后(中位数 = 2.5小时),而低剂量组为14.3%(中位数 = 2.38小时)。

结论

估算肾小球滤过率低的患者使用高剂量或低剂量胰岛素时,低血糖或严重低血糖的发生率没有差异。我们建议在高钾血症患者使用胰岛素后监测长达6小时。

相似文献

1
Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia.使用胰岛素和葡萄糖治疗高钾血症的估算肾小球滤过率低的患者发生低血糖的发生率。
Ann Pharmacother. 2015 Dec;49(12):1322-6. doi: 10.1177/1060028015607559. Epub 2015 Sep 28.
2
A Comparison of Insulin Doses for the Treatment of Hyperkalemia in Patients with Renal Insufficiency.比较肾功能不全患者治疗高钾血症的胰岛素剂量。
Pharmacotherapy. 2017 Dec;37(12):1516-1522. doi: 10.1002/phar.2038. Epub 2017 Nov 27.
3
Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment.高钾血症胰岛素治疗急性稳定后低血糖的发生率。
J Hosp Med. 2012 Mar;7(3):239-42. doi: 10.1002/jhm.977.
4
Assessment of dextrose 50 bolus versus dextrose 10 infusion in the management of hyperkalemia in the ED.急诊室中葡萄糖 50 推注与葡萄糖 10 输注治疗高钾血症的评估。
Am J Emerg Med. 2020 Mar;38(3):598-602. doi: 10.1016/j.ajem.2019.09.003. Epub 2019 Nov 16.
5
Current hyperkalemia interventions co-administered with a dextrose 10% solution significantly lower hypoglycemic rates (CHICA-D10).含 10%葡萄糖溶液的低钾血症干预措施显著降低低血糖发生率(CHICA-D10)。
Am J Emerg Med. 2024 Oct;84:120-123. doi: 10.1016/j.ajem.2024.07.061. Epub 2024 Aug 3.
6
Evaluation of Insulin Dosing Strategies for Hyperkalemia Management at an Academic Medical Center.评估学术医疗中心高钾血症管理中的胰岛素给药策略。
Clin Ther. 2024 May;46(5):382-388. doi: 10.1016/j.clinthera.2024.03.003. Epub 2024 Apr 8.
7
Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia.降低住院高钾血症患者胰岛素治疗后低血糖的发生。
J Hosp Med. 2020 Feb;15(2):368-370. doi: 10.12788/jhm.3357.
8
Impact of a Hyperkalemia Protocol Tailored to Glucose Concentration and Renal Function on Insulin-Induced Hypoglycemia in Patients with Low Pretreatment Glucose.根据血糖浓度和肾功能调整的高钾血症方案对低血糖预处理患者胰岛素诱导低血糖的影响。
J Emerg Med. 2024 Apr;66(4):e421-e431. doi: 10.1016/j.jemermed.2023.12.001. Epub 2023 Dec 12.
9
The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia.胰岛素-葡萄糖治疗与高钾血症患者低血糖的关联。
Sci Rep. 2020 Dec 16;10(1):22044. doi: 10.1038/s41598-020-79180-7.
10
Hypoglycemia as a complication of intravenous insulin to treat hyperkalemia in the emergency department.低血糖症作为静脉用胰岛素治疗急诊科高钾血症的并发症。
Am J Emerg Med. 2019 Feb;37(2):209-213. doi: 10.1016/j.ajem.2018.05.016. Epub 2018 May 10.

引用本文的文献

1
Management of hyperkalemia: strategic clinical actions in real-world practice.高钾血症的管理:现实临床实践中的策略性临床行动
Clin Exp Nephrol. 2025 Jul 24. doi: 10.1007/s10157-025-02728-2.
2
Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function.肾功能减退患者静脉注射胰岛素治疗高钾血症
J Clin Med. 2024 Aug 28;13(17):5103. doi: 10.3390/jcm13175103.
3
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study.
帕替罗默作为需要紧急血钾管理的患者的辅助治疗药物的效用(PLATINUM):一项多中心、随机、双盲、安慰剂对照、平行组研究的设计。
BMJ Open. 2023 Jun 12;13(6):e071311. doi: 10.1136/bmjopen-2022-071311.
4
Acute hyperkalemia in adults.成人急性高钾血症
Turk J Emerg Med. 2023 Mar 2;23(2):75-81. doi: 10.4103/tjem.tjem_288_22. eCollection 2023 Apr-Jun.
5
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.美国临床内分泌学会临床实践指南:制定糖尿病综合护理计划-2022 更新版。
Endocr Pract. 2022 Oct;28(10):923-1049. doi: 10.1016/j.eprac.2022.08.002. Epub 2022 Aug 11.
6
Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review.因治疗高钾血症而接受胰岛素治疗导致的住院成人低血糖:范围综述。
PLoS One. 2022 May 12;17(5):e0268395. doi: 10.1371/journal.pone.0268395. eCollection 2022.
7
Frequency of serum blood glucose monitoring after hyperkalaemia treatment using insulin and dextrose.使用胰岛素和葡萄糖治疗高钾血症后血清血糖监测的频率
J Taibah Univ Med Sci. 2021 Sep 4;17(1):82-86. doi: 10.1016/j.jtumed.2021.07.014. eCollection 2022 Feb.
8
Hyperkalemia management in the emergency department: An expert panel consensus.急诊科高钾血症的管理:专家小组共识
J Am Coll Emerg Physicians Open. 2021 Oct 1;2(5):e12572. doi: 10.1002/emp2.12572. eCollection 2021 Oct.
9
[Cardiac arrest under special circumstances].[特殊情况下的心脏骤停]
Notf Rett Med. 2021;24(4):447-523. doi: 10.1007/s10049-021-00891-z. Epub 2021 Jun 10.
10
The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia.胰岛素-葡萄糖治疗与高钾血症患者低血糖的关联。
Sci Rep. 2020 Dec 16;10(1):22044. doi: 10.1038/s41598-020-79180-7.